x If the source is known or shown to be positive for HBsAg, the level of anti-HBs antibodies in 
the HCW is important. If the injured HCW is immunized (anti-HBs antibodies >10 IU/ml)– whether from vaccination or past infection they are protected, and there is no need for hepatitis B immunoglobulin after a potential or conﬁ  rmed exposure to hepatitis B.
x When a source patient is unknown, the exposed HCW should be managed as if the source 
patient were HBsAg-positive.
x When indicated, immune prophylaxis should be initiated as soon as possible, preferably 
within 24 hours.
x If the HCW is unimmunized or a non-responder (did not seroconvert to the vaccine) or has